OCT News

  • Mar 21, 2017

    Contract research organizations in today’s pharmaceutical market

    When outsourcing clinical trials to CROs, sponsors delegate a number of activities (medical, scientific, statistical, managerial, regulatory, etc.) to their vendors. Each of these activities requires special expertise and skills.
  • Mar 14, 2017

    OCT to obtain approval for a phase I clinical study

    This is a double-blind, randomized, placebo-controlled multiple-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the investigational drug in healthy volunteers.
  • Mar 3, 2017

    OCT reaches 50% enrollment milestone 3 months earlier than planned

    This is a phase III, randomised, double-blind, multicenter study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity of the investigational medicinal drug.
  • Feb 27, 2017

    Strategic development of biotech projects

    On February 20, 2017, OCT project manager Irina Ivushkina spoke at the International Biotechnology Congress. Her presentation was a part of ‘Strategic development of biotech projects: working stages and tools’ panel discussion, hosted by Primer Capital venture fund.  

Meet Us

OCT Case study